Metastaza karcinoma bubrega u nosno-sinusnoj šupljini by Marijan Kovačić et al.
Acta Clin Croat,  Vol. 54,   No. 2,  2015 22�
Acta Clin Croat 2015; 54:223-226 Case Report
RenAl Cell CARCinomA meTASTASiS To The 
SinonASAl CAviTy: CASe RepoRT*
marijan Kovačić1, Ana Krvavica2 and milan Rudić1
1Department of enT and head and neck Surgery, 2Department of pathology and Forensic medicine, Zadar 
General hospital, Zadar, Croatia
SUmmARy – Renal cell carcinoma accounts for 3% of all adult malignant tumors. Common 
sites of metastases are lungs, bone, liver, brain and adrenal glands. metastatic disease to the head 
and neck ranges from 15% to 30%. The 5-year survival rate after nephrectomy is 60%-75%, but with 
multiorgan metastases the 5-year survival rate is significantly lower, 0-7%. A case is presented of a 
female patient diagnosed with renal cell carcinoma metastases to the paranasal sinuses, diagnosed 
and treated at the Department of enT and head and neck Surgery, Zadar General hospital, Za-
dar, Croatia. The tumor was surgically removed. Unfortunately, the patient died one year after the 
procedure due to multiorgan failure. Although metastases of renal cell carcinoma to the head and 
neck are very rare, it should be first suspected when investigating a metastatic tumor in this region. 
Surgical excision offers the best hope for long term survival. in case of unresectable tumor, other 
treatment options should be considered such as radiotherapy, immunotherapy and chemotherapy.
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Inroduction
Renal cell carcinoma (RCC) accounts for 3% of 
all adult malignant tumors1,2. About 20%-50% of 
RCC patients will eventually develop metastasis af-
ter nephrectomy2. Common sites of metastases are 
lungs (76%), bone (42%), liver (41%), brain and adre-
nal glands1,3. metastatic disease to the head and neck 
ranges from 15% to 30%3,4. metastases to the sinona-
sal cavity are very rare. most malignant tumors oc-
curring in the nasal and paranasal sinuses are primary 
ones, while metastatic tumors in this region are very 
rare5,6. metastatic RCC to the sinonasal cavity pres-
ents as an intranasal mass causing recurrent epistaxis, 
nasal obstruction, facial pain and orbital mass1,4,5,7. The 
overall prognosis of a renal metastatic disease to the 
nose and paranasal sinuses is very poor. nevertheless, 
recent studies have shown that these lesions can have 
a very good response to higher doses of radiotherapy1. 
metastases of RCC to the head and neck skin are also 
very rare (9%) and up to now only 80 cases have been 
reported in the literature6.
We report on a female patient with metastatic 
RCC to the nasal cavity. We discuss its clinical pre-
sentation, treatment and final outcome.
Case Report
A 61-year-old female patient presented to the enT 
Department due to episodes of recurrent epistaxis and 
continuous nasal obstruction. previously, she was 
treated at the Department of Urology due to RCC. 
She was operated on (nephrectomy) and received ra-
diotherapy treatment. Follow up multisystem com-
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puted tomography (CT) scan showed multiple RCC 
metastases to the liver, pancreas and vertebrae. She 
received palliative chemotherapy at the Department 
of oncology. Upon admission to the enT Depart-
ment, local finding showed a tumor mass filling and 
protruding from the nasal cavity (Fig. 1). paranasal 
sinus CT scan showed a soft-tissue mass in the nasal 
cavity with no erosion of the surrounding bone (Fig. 
2). Under local anesthesia, the patient underwent tu-
mor removal, transnasal endoscopic approach. After 
intranasal topical decongestion, we injected lidocaine 
with epinephrine (1:100,000) along the inferior and 
medial meatal wall. initial horizontal incision was 
performed at the site of the anesthetic application. 
Attachment of the inferior turbinate to the lateral na-
sal wall was severed with endoscopic scissors straight 
osteotome following bipolar cautery. pathologic find-
ings were consistent with metastatic RCC. The tumor 
measured 3 cm in longest diameter, dark-red colored, 
mainly thrombotic, with broad areas of hemorrhage 
and inflammation (Fig. 3). microscopically, the tu-
mor showed alveolar pattern of cells with abundant, 
clear cytoplasm and large, oval, hyperchromatic nu-
clei, conspicuous nucleoli, and brisk mitotic activity. 
To confirm the diagnosis of metastatic clear cell car-
cinoma, immunohistochemical staining for Cytoker-
atin-7 (DAKo, Denmark; dilution 1:50), Cytokera-
tin-18 (DAKo, Denmark; dilution 1:25), epithelial 
membrane antigen (emA, DAKo, Denmark; dilu-
tion 1:50) and vimentin (DAKo, Denmark; dilu-
tion 1:3000) was performed. immunohistochemical 
examination showed diffusely positive reaction with 
emA and vimentin mononuclear antibodies, but Cy-
tokeratin-18 and Cytokeratin-7 were negative (Figs. 
4 and 5). The patient was referred to the oncology 
Fig. 1. Tumor mass protrusion from the nasal cavity.
Fig. 2. Computed tomography scan showing soft tumor mass in the nasal cavity with no calcification or erosion of the 
surrounding bone: frontal (A), horizontal (B) and sagittal (C) projection.
Fig. 3. Dark-red colored excised tumor measuring 3 cm in 
longest diameter.
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Department for further treatment. Unfortunately, six 
months after the surgery, the patient died due to com-
plications of multiorgan failure.
Discussion
About 14%-16% of RCC patients have metastases 
above the clavicle, which makes this tumor the third 
most frequent infraclavicular primary tumor to me-
tastasize to the head and neck and the first to metasta-
size to the sinonasal region1,3,4,7. Sinonasal metastasis 
can be the presenting feature of RCC in almost 8% 
of patients1. nevertheless, only 1% of patients with 
the hypernephroid type of RCC have no other obvi-
ous metastasis except for the head and neck1. Thyroid 
gland is the most common site of metastasis for this 
tumor, but it can also occur in the cervical lymphatic 
vessels, the mandible, the sinonasal cavity, and the 
skin of the face and scalp1,3. We report on a case of 
RCC metastases to the head and neck region (nasal 
cavity). The clinical course of these tumors is very par-
ticular; while some hypernephromas regress sponta-
neously, others demonstrate metastases several years 
after initial treatment. indeed, a case of a recurrent 
disease 17 years after initial nephrectomy has been re-
ported3. in our case, the recurrent disease to the head 
and neck appeared two years after initial treatment. 
The metastatic spread to the head and neck is either 
via hematogenous route (invasion of the local vascular 
network; through the atrial septal defect; bypassing 
the pulmonary capillary filtration mechanisms; tumor 
emboli travelling past the inferior vena cava; associ-
ated multiple arteriovenous shunts) or an alternative 
lymphatic route (via regional lymphatic vessels into 
the thoracic duct). once the tumor reaches the head 
and neck, it can anastamose with the great veins of the 
head and spread to the nose and sinuses, face and scalp 
skin and thyroid gland1,4,5. Due to a very vascular tu-
mor stroma, epistaxis is the most common symptom 
of the sinonasal tumor metastasis.
high vascularity of the tumor is caused by hippel-
lindau gene mutation responsible for up-regulation 
of hypoxia induced factor 1a that causes angiogen-
esis through vascular endothelial growth factor up-
regulation. other possible symptoms of the sinonasal 
tumor metastases are nasal obstruction, facial pain 
and swelling, orbital pain and protrusion5,8,9. in the 
present case, recurrent epistaxis and nasal obstruction 
were the leading symptoms of the disease. Differen-
tial diagnosis of a sinonasal lesion with epistaxis in-
cludes hemangioma, angioendothelioma, Wegener’s 
granulomatosis and midline granuloma. however, a 
bleeding necrotic mass in the sinonasal cavity should 
always be suspected of primary RCC that need to be 
either diagnosed or ruled out.
Radiological examination (CT scan) is valuable in 
the diagnosis of the disease extent. RCC metastases 
to the sinonasal tract have similar radiological appear-
ances to the primary malignant lesions in this region. 
The enhancement, destruction, and lack of tumor cal-
cification should suggest metastatic hypernephroma1. 
Fig. 4. Strongly positive cytoplasmic immunostaining 
with epithelial membrane antigen (EMA, X100).
Fig. 5. Strongly positive cytoplasmic immunostaining 
(vimentin, X100).
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in the present case, CT scan showed a soft tissue 
mass, with no destruction of the surrounding bone 
structures and no calcification.
Renal cell carcinoma metastases are mainly mul-
tiple, but metastases in the sinonasal cavity are usually 
single. patients with single lesions should be treated 
surgically very aggressively because it offers the best 
possible treatment outcome. in cases of multiple tu-
mors, surgery is mainly limited to tumor debulking 
and diagnostic purposes.
Another possible treatment option for these tumors 
is radiotherapy1,10. While these tumors are primarily 
described as radio-resistant, recent studies showed 
good radiotherapy responses (palliative response in 
86% of treated patients)1,3,4. Furthermore, immuno-
therapy has also been proposed as a possible optional 
treatment for metastatic RCC5,10. in general, the 
5-year survival rate after nephrectomy is 60%-75%; 
however, with multiorgan metastases, the 5-year sur-
vival rate is significantly lower, 0-7%3. Unfortunately, 
our patient died within the first year of metastasis 
treatment due to the extensive tumor involvement of 
multiple internal organs.
Conclusion
Although RCC metastasis to the head and neck is 
very rare, it should be first suspected when investigat-
ing a metastatic tumor in this region. Surgical excision 
offers the best hope for long term survival and reduces 
pain, epistaxis, and disfigurement from the expanding 
tumor. in case of unresectable tumor, other treatment 
options should be considered such as radiotherapy, 
immunotherapy and chemotherapy.
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Sažetak
meTASTAZA KARCinomA BUBReGA U noSno-SinUSnoJ šUplJini
M. Kovačić, A. Krvavica i M. Rudić
od svih malignih tumora ljudskog organizma tumor bubrega je zastupljen u oko 3% slučajeva. Česta mjesta metasta-
ziranja su pluća, kosti, jetra, mozak i nadbubrežna žlijezda. pojava metastaza ovoga karcinoma u području glave i vrata 
kreće se oko 15%-30%. postotak petogodišnjeg preživljenja nakon nefrektomije je 60%-75%, dok je istovjetno preživljenje s 
prisutnim metastazama znatno kraće, 0-7%. U ovom radu prikazuje se bolesnica kojoj je dijagnosticiran karcinom bubrega 
s metastazom u nosnoj šupljini i paranazalnim sinusima. Dijagnostički postupak i kirurško liječenje obavljeno je u općoj 
bolnici Zadar, odjel otorinolaringologije i kirugije glave i vrata. Tumor je uspješno kirurški odstranjen, ali je bolesnica 
preminula nakon godinu dana zbog višeorganskih metastaza. metastaza bubrežnog karcinoma u području glave i vrata je 
vrlo rijetka. Kirurška ekscizija je metoda izbora, a u slučaju neresektabilnog tumora moguće je primijeniti radioterapiju, 
imunoterapiju i kemoterapiju. 
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